Annual EBITDA
-$15.11 M
+$7.26 M+32.45%
01 December 2023
Summary:
Catheter Precision annual earnings before interest, taxes, depreciation & amortization is currently -$15.11 million, with the most recent change of +$7.26 million (+32.45%) on 01 December 2023. During the last 3 years, it has risen by +$12.59 million (+45.45%). VTAK annual EBITDA is now -268.27% below its all-time high of -$4.10 million, reached on 01 December 2016.VTAK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$3.56 M
-$1.37 M-62.39%
01 September 2024
Summary:
Catheter Precision quarterly earnings before interest, taxes, depreciation & amortization is currently -$3.56 million, with the most recent change of -$1.37 million (-62.39%) on 01 September 2024. Over the past year, it has dropped by -$56.77 million (-106.69%). VTAK quarterly EBITDA is now -106.69% below its all-time high of $53.22 million, reached on 01 December 2023.VTAK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$45.37 M
-$2.15 M-4.53%
01 September 2024
Summary:
Catheter Precision TTM earnings before interest, taxes, depreciation & amortization is currently $45.37 million, with the most recent change of -$2.15 million (-4.53%) on 01 September 2024. Over the past year, it has increased by +$3.98 million (+9.61%). VTAK TTM EBITDA is now -5.97% below its all-time high of $48.26 million, reached on 01 March 2024.VTAK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTAK EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -106.7% | +9.6% |
| 3 y3 years | +45.5% | +55.2% | +263.8% |
| 5 y5 years | +72.5% | +61.4% | +182.6% |
VTAK EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.5% | -106.7% | +60.3% | -6.0% | +263.8% |
| 5 y | 5 years | at high | +72.5% | -106.7% | +63.3% | -6.0% | +182.6% |
| alltime | all time | -268.3% | +72.5% | -106.7% | +78.9% | -6.0% | +175.1% |
Catheter Precision EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.56 M(+62.4%) | $45.37 M(-4.5%) |
| June 2024 | - | -$2.19 M(+4.6%) | $47.52 M(-1.5%) |
| Mar 2024 | - | -$2.09 M(-103.9%) | $48.26 M(+16.6%) |
| Dec 2023 | -$15.11 M(-32.4%) | $53.22 M(-3882.3%) | $41.40 M(-307.9%) |
| Sept 2023 | - | -$1.41 M(-3.6%) | -$19.91 M(-12.2%) |
| June 2023 | - | -$1.46 M(-83.7%) | -$22.67 M(-12.8%) |
| Mar 2023 | - | -$8.95 M(+10.7%) | -$26.00 M(+16.3%) |
| Dec 2022 | -$22.37 M(-19.3%) | -$8.09 M(+94.1%) | -$22.37 M(+0.6%) |
| Sept 2022 | - | -$4.17 M(-13.1%) | -$22.23 M(-11.4%) |
| June 2022 | - | -$4.80 M(-9.8%) | -$25.09 M(-5.7%) |
| Mar 2022 | - | -$5.32 M(-33.1%) | -$26.60 M(-4.0%) |
| Dec 2021 | -$27.70 M(-16.1%) | -$7.95 M(+13.2%) | -$27.70 M(-6.0%) |
| Sept 2021 | - | -$7.03 M(+11.3%) | -$29.46 M(+0.5%) |
| June 2021 | - | -$6.31 M(-1.6%) | -$29.31 M(-9.7%) |
| Mar 2021 | - | -$6.42 M(-33.9%) | -$32.47 M(-2.1%) |
| Dec 2020 | -$33.04 M | -$9.71 M(+41.2%) | -$33.15 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$6.88 M(-27.4%) | -$32.66 M(-23.5%) |
| June 2020 | - | -$9.47 M(+33.4%) | -$42.66 M(-10.7%) |
| Mar 2020 | - | -$7.10 M(-23.0%) | -$47.80 M(-13.0%) |
| Dec 2019 | -$54.94 M(+82.0%) | -$9.21 M(-45.4%) | -$54.94 M(-9.1%) |
| Sept 2019 | - | -$16.88 M(+15.6%) | -$60.41 M(+25.4%) |
| June 2019 | - | -$14.60 M(+2.5%) | -$48.18 M(+15.2%) |
| Mar 2019 | - | -$14.24 M(-3.0%) | -$41.83 M(+38.6%) |
| Dec 2018 | -$30.18 M(+72.1%) | -$14.68 M(+215.8%) | -$30.18 M(+62.9%) |
| Sept 2018 | - | -$4.65 M(-43.7%) | -$18.52 M(+19.3%) |
| June 2018 | - | -$8.26 M(+218.0%) | -$15.53 M(-16.1%) |
| Mar 2018 | - | -$2.60 M(-14.2%) | -$18.51 M(+5.5%) |
| Dec 2017 | -$17.54 M(+327.5%) | -$3.02 M(+82.4%) | -$17.54 M(+20.8%) |
| Sept 2017 | - | -$1.66 M(-85.2%) | -$14.52 M(+12.9%) |
| June 2017 | - | -$11.23 M(+589.3%) | -$12.86 M(+689.3%) |
| Mar 2017 | - | -$1.63 M | -$1.63 M |
| Dec 2016 | -$4.10 M | - | - |
FAQ
- What is Catheter Precision annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Catheter Precision?
- What is Catheter Precision quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Catheter Precision?
- What is Catheter Precision quarterly EBITDA year-on-year change?
- What is Catheter Precision TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Catheter Precision?
- What is Catheter Precision TTM EBITDA year-on-year change?
What is Catheter Precision annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of VTAK is -$15.11 M
What is the all time high annual EBITDA for Catheter Precision?
Catheter Precision all-time high annual earnings before interest, taxes, depreciation & amortization is -$4.10 M
What is Catheter Precision quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of VTAK is -$3.56 M
What is the all time high quarterly EBITDA for Catheter Precision?
Catheter Precision all-time high quarterly earnings before interest, taxes, depreciation & amortization is $53.22 M
What is Catheter Precision quarterly EBITDA year-on-year change?
Over the past year, VTAK quarterly earnings before interest, taxes, depreciation & amortization has changed by -$56.77 M (-106.69%)
What is Catheter Precision TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of VTAK is $45.37 M
What is the all time high TTM EBITDA for Catheter Precision?
Catheter Precision all-time high TTM earnings before interest, taxes, depreciation & amortization is $48.26 M
What is Catheter Precision TTM EBITDA year-on-year change?
Over the past year, VTAK TTM earnings before interest, taxes, depreciation & amortization has changed by +$3.98 M (+9.61%)